LM1104

17:0-14:1 PE

Avanti Research^™ - A Croda Brand

• Synonym(e): 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phosphoethanolamine
• Empirische Formel (Hill-System): C₃₆H₇₀NO₈P
• CAS-Nummer: 958763-89-8
• Molekulargewicht: 675.92
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Form: methanol solution
• Verpackung: pkg of 1 × 1 mL (LM1104-1EA)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand
• Konzentration: ~10 μg/mL (Refer to C of A for lot specific concentration.)
• Anwendung(en): lipidomics; metabolomics
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: [H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\CCCC)=O)COC(CCCCCCCCCCCCCCCC)=O
• InChIKey: QWRIURIVRIHUFS-PEDHGXIFSA-N

Beschreibung

Allgemeine Beschreibung

Phosphoethanolamine (PE) acts as a parent compound for phosphatidylcholine and phosphatidylethanolamine synthesis.

Anwendung

17:0-14:1 PE or 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phosphoethanolamine has been used as an internal standard:

• for lipid quantification using liquid chromatography-mass spectrometry (LC-MS)
• for the detection of lipids by tandem mass spectrometry (MS/MS) (related to lipidome analyses)
• in lipid extraction using MTBE protocol

Biochem./physiol. Wirkung

Phosphoethanolamine (PE) is known to show extensive antitumor action and prevents tumor proliferation, in vivo. Synthetic PE inhibits lung metastasis.

Verpackung

2 mL Amber Glass Sealed Ampule (LM1104-1EA)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS02,GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H225,H301 + H311 + H331,H370
• P-Sätze: P210 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311
• Gefahreneinstufungen: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• Zielorgane: Eyes
• Lagerklassenschlüssel: 3 - Flammable liquids
• WGK: WGK 2
• Flammpunkt (°F): 49.5 °F - closed cup
• Flammpunkt (°C): 9.7 °C - closed cup